Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 22, 2025, 12:43
AQUATIC Trial: Validates Stopping ASA Improves Safety and Efficacy in CAD
Christopher Cannon, Editor in Chief, Harvard Health Publishing, shared a post on LinkedIn:
“Very important trial: AQUATIC: dropping ASA in CAD patients on anticoagulation improves both safety – and efficacy!
This validates the prior findings from the AFIRE trial.
For patients on anticoagulation, we need to look to stop the aspirin for long-term treatment.”
Read full article here.

Title: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Authors: Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, Tabassome Simon, Gilles Montalescot, Nicolas Danchin, Christophe Bauters
Stay updated with Hemostasis Today.
AFIRE Trial
Anticoagulation
AQUATIC
ASA
Aspirin
CAD
Christophe Bauters
Christopher Cannon
Chronic Coronary Syndrome
Gilles Lemesle
Gilles Montalescot
Headlines
Health
Hematology
Hemostasis
Hemostasis Today
Medicine
Nicolas Danchin
Oral Anticoagulation
Philippe Gabriel Steg
Romain Didier
Tabassome Simon
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis
-
Nov 18, 2026, 20:55Nasir Jamal: Plasmapheresis – Key Concepts at a Glance
-
Nov 18, 2026, 20:55Tarık Seller: Pulmonary Embolism – When a Blood Clot Becomes a Life-Threatening Emergency
-
Nov 18, 2026, 20:53Sandya Arunachalam: Bringing the Profession Together at the Haemostasis and Thrombosis Workshop
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency